- Home
- ZIMV vs TMCI Comparison
ZIMV vs TMCI Comparison
Compare ZIMV & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZIMV
- TMCI
- Stock Information
- Founded
- ZIMV 2021
- TMCI 2014
- Country
- ZIMV United States
- TMCI United States
- Employees
- ZIMV N/A
- TMCI N/A
- Industry
- ZIMV Biotechnology: Electromedical & Electrotherapeutic Apparatus
- TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ZIMV Health Care
- TMCI Health Care
- Exchange
- ZIMV Nasdaq
- TMCI Nasdaq
- Market Cap
- ZIMV 400.7M
- TMCI 464.4M
- IPO Year
- ZIMV N/A
- TMCI 2021
- Fundamental
- Price
- ZIMV $13.60
- TMCI $6.96
- Analyst Decision
- ZIMV Hold
- TMCI Hold
- Analyst Count
- ZIMV 3
- TMCI 7
- Target Price
- ZIMV $18.33
- TMCI $7.90
- AVG Volume (30 Days)
- ZIMV 132.0K
- TMCI 384.2K
- Earning Date
- ZIMV 10-30-2024
- TMCI 11-05-2024
- Dividend Yield
- ZIMV N/A
- TMCI N/A
- EPS Growth
- ZIMV N/A
- TMCI N/A
- EPS
- ZIMV N/A
- TMCI N/A
- Revenue
- ZIMV $451,294,000.00
- TMCI $202,861,000.00
- Revenue This Year
- ZIMV $0.70
- TMCI $13.15
- Revenue Next Year
- ZIMV $1.07
- TMCI $8.36
- P/E Ratio
- ZIMV N/A
- TMCI N/A
- Revenue Growth
- ZIMV 267.15
- TMCI 16.14
- 52 Week Low
- ZIMV $13.01
- TMCI $3.92
- 52 Week High
- ZIMV $22.40
- TMCI $15.98
- Technical
- Relative Strength Index (RSI)
- ZIMV 41.07
- TMCI 39.76
- Support Level
- ZIMV $13.75
- TMCI $6.75
- Resistance Level
- ZIMV $14.29
- TMCI $7.75
- Average True Range (ATR)
- ZIMV 0.52
- TMCI 0.38
- MACD
- ZIMV -0.06
- TMCI -0.21
- Stochastic Oscillator
- ZIMV 16.27
- TMCI 10.34
About ZIMV ZimVie Inc.
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.
About TMCI Treace Medical Concepts Inc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals.